VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
3D Bioprinting Market Size to Surpass USD 8.57 Billion by 2034 [Yahoo! Finance]